MindWalk Holdings (HYFT) Finished Goods (2022 - 2026)
MindWalk Holdings (HYFT) posted quarterly Finished Goods of $358917.0 for Q2 2026, down 70.2% year-over-year from $1.2 million in Q2 2025, and down 70.2% quarter-over-quarter from $1.2 million in Q2 2025.
MindWalk Holdings (HYFT) Finished Goods (2022 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Finished Goods for 5 consecutive years, with $358917.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Finished Goods fell 70.2% year-over-year to $358917.0; the TTM figure through Apr 2026 stood at $358917.0 (down 70.2% YoY), while the FY2026 annual figure was $358917.0, down 70.83% from the prior year.
- Finished Goods eased to $358917.0 in Q2 2026 per HYFT's latest filing, from $1.2 million in the prior quarter.
- Across five years, Finished Goods topped out at $1.3 million in Q2 2024 and bottomed at $358917.0 in Q2 2026.
- Historically, Finished Goods has averaged $991025.1 across 5 years, with a median of $1.1 million in 2022.
- Annual changes were most pronounced in 2024 — Finished Goods grew 28.75% — and 2026, when it tumbled 70.2%.
- MindWalk Holdings' Finished Goods stood at $1.1 million in 2022, then declined by 11.28% to $993282.1 in 2023, then advanced by 28.75% to $1.3 million in 2024, then retreated by 5.82% to $1.2 million in 2025, then slumped by 70.2% to $358917.0 in 2026.
- Business Quant data shows HYFT's Finished Goods at $358917.0 in Q2 2026, $1.2 million in Q2 2025, and $1.3 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 358,916.96 |
| Apr 30, 2025 | 1.20 Mn |
| Apr 30, 2024 | 1.28 Mn |
| Apr 30, 2023 | 993,282.10 |
| Apr 30, 2022 | 1.12 Mn |